Stroke
Conditions
Keywords
Telehealth, Rehabilitation, Care partner, Sub-acute stroke, CARE-CITE, Stroke survivors
Brief summary
Carepartner and Collaborative Integrated Therapy (CARE-CITE) is a novel, web-based carepartner focused intervention designed to foster problem solving and skill building while facilitating carepartner engagement during upper extremity functional activities in the home setting. The proposed study will evaluate the application of the CARE-CITE intervention paired with usual and customary care during the sub-acute stroke.
Detailed description
Stroke is a leading cause of serious, long-term disability in the United States, and has a particularly harmful impact on individuals and families. Approximately 4.8 million stroke survivors require assistance from family members who are often untrained and ill prepared for the burdens associated with stroke rehabilitation. Family carepartners are key contributors to stroke recovery, but their efforts can lead them to experience a high level of burden and depressive symptoms, reduced quality of life and increased stress in the context of high levels of family conflict surrounding the recovery process. Rehabilitation therapy interventions have primarily targeted stroke survivor outcomes without specifically addressing the well-being of the carepartner. The researchers of this study have developed a theory-based, family-centered intervention, Carepartner and Collaborative Integrated Therapy (CARE-CITE), designed to engage carepartners during stroke survivor upper extremity (UE) functional task practice in the home. Residual UE impairments occur in up to 80% of stroke survivors and are a primary factor in loss of functional independence. CARE-CITE guides the carepartner in collaborative goal setting and providing autonomy support (characterized by empathy, choice and reducing use of controlling language) for the stroke survivor to promote motivation and creative problem solving in UE self-management. Participating stroke survivor and carepartner dyads will be randomized to receive the CARE-CITE intervention with usual customary care, or usual customary care alone for four weeks.
Interventions
The primary CARE-CITE components will be education via web platform. Carepartners complete 6 online CARE-CITE modules (15-30-minute sessions each). The modules include demonstration videos and instructive content covering following areas: principles of functional task practice (i.e., activities of daily living such as eating, grooming, or leisure/vocational activities), adaptation of tasks, and importance of progression of challenging tasks to drive neuroplasticity (i.e., increasing numbers of practice repetitions or weight of objects lifted). Underpinning the content is the concept of autonomy support, with examples of fostering empathy, problem solving, instruction in the use of non-controlling language with role playing situations and the importance of creating choice in activities.
The carepartner will receive a support brochure with general caregiving information including website resources to mimic web interaction of intervention group (e.g., stroke caregiver resource site).
Sponsors
Study design
Eligibility
Inclusion criteria
for Stroke Survivors: * 1-3 months post ischemic or hemorrhagic event * discharged from inpatient neurologic rehabilitation to their home * have minimal to moderate upper extremity (UE) deficits (actively initiate 20 degrees of wrist and 10 degrees of finger extension) * no severe cognitive deficits (Mini -mental test \>24) * no physician determined major medical problems that would limit participation in outpatient therapy Inclusion Criteria for Carepartners: * spouse/partner or family member * dwelling in the same household * self-identify as the primary caregiver of the stroke survivor * \>21 years old * able to read and write English * have no significant cognitive deficits (Mini -mental test \>24) * familiar with using a computer and accessing websites, or with using a tablet
Exclusion criteria
* none
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Center for Epidemiologic Studies - Depression (CES-D) Scale Score Among Carepartners | Baseline, 2 months post-intervention | Depression among carepartners was assessed with the CES-D. The CES-D is 20-item, 4-point Likert-type scale where 0 = none/rare and 3 = most or all of the time. The scoring of positive items is reversed. The possible range of scores is 0 to 60, with the higher scores indicating the presence of more symptomatology. Unadjusted means are presented here. |
| Short Form Health Survey (SF-36) Scale Score Among Carepartners | Baseline, 2 months post-intervention | Carepartner quality of life was assessed with the SF-36. The SF-36 is a 36-item Likert-type scale, mental health domain. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. Lower scores indicate greater disability, while higher scores indicate less disability (i.e. a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability). Unadjusted means are presented here. |
| Wolf Motor Function Test (WMFT) Upper Extremity Function Ability Score (FAS) | Baseline, 2 months post-intervention | The Wolf Motor Function Test (WMFT) assesses upper extremity motor ability with 17 timed and functional tasks (15 timed and 2 strength tasks). Functional ability for each task is scored from 0 to 5, where 0 = does not attempt with upper extremity being tested, and 5 = movement appears to be normal. Total scores range from 0 to 85 and lower scores indicate lower functional ability. Unadjusted means are presented here. |
| Wolf Motor Function Test (WMFT) Test Time Among Stroke Survivors | Baseline, 2 months post-intervention | The Wolf Motor Function Test (WMFT) assesses upper extremity motor ability with 17 functional tasks (15 timed and 2 strength tasks). The time, in seconds, required to complete each of 15 timed scores is calculated, with lower times (faster speeds) indicating higher functioning levels. Unadjusted means are presented here. |
| Quality of Upper Extremity Function by Motor Activity Log (MAL) Score Among Stroke Survivors | Baseline, 2 months post-intervention | The Motor Activity Log is 30-item questionnaire assessing use of the affected arm during normal daily activities. Responses are given on a Likert scale where 0 = the weaker arm was not used at all for that activity (never) to 5 = the ability to use the weaker arm for that activity was as good as before the stroke (normal). The total score is the average of all items and ranges from 0 to 5, where higher values indicate greater function of the arm that was impacted by the stroke. Unadjusted means are presented here. |
| Stroke Impact Scale (SIS) Score Among Stroke Survivors | Baseline, 2 months post-intervention | Quality of life among stroke survivors was assessed with the Stroke Impact Scale (SIS). The SIS is a stroke specific, self report questionnaire (59 items across 8 domains) that measures how a stroke has impacted a participant's health and life, including strength, memory and thinking, emotions and mood, communication, activities of daily living, mobility, function of affected upper extremity, and social participation. Each item is rated in a 5-point Likert scale in terms of the difficulty the participant has experienced in completing each item. A score for each domain is obtained, ranging from 0 to 100 where higher scores indicate greater ability to perform tasks. Unadjusted means are presented here. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Bakas Caregiving Outcomes Scale (BCOS) Score | Baseline, 2 months post-intervention | The BCOS is a unidimensional scale based on 15 items and addresses changes in caregiving social functioning, subjective well-being and physical health. Carepartners respond to statements on a 7-point Likert scale where 1 = changed for the worst, and 7 = changed for the best. Total scores range from 15 - 105 with higher scores representing more positive caregiving outcomes since the stroke. Unadjusted means are presented here. |
| Fugl-Meyer Assessment (FMA) Upper Extremity Motor Score | Baseline, 2 months post-intervention | Upper extremity impairment was assessed by the Fugl-Meyer Assessment (FMA). The FMA evaluates and measures recovery in post-stroke hemiplegic patients with 5 domains: motor score (which is further separated for upper and lower extremity), sensation, balance, joint range of motion, and joint pain. Items are scored on a 3-point ordinal scale where 0 = cannot perform and 3 = performs fully. The total score for the upper extremity motor domain ranges from 0 to 66 and a higher score indicates greater arm function. Unadjusted means are presented here. |
| Family Care Climate Questionnaire - Carepartners (FCCQ-CP) Score | Baseline, 2 months post-intervention | The Family Care Climate Questionnaire (FCCQ) for carepartners is 14-item questionnaire asking about the carepartners' experiences with the strokes survivor in relation to their rehabilitation activities. Each item is rated on a 7-point Likert scale ranging from 1 (not true at all) to 7 (very true). Item scores are averaged to provide an overall score between 1 and 7 where higher scores indicate the carepartner thinks they are providing high autonomy support to the stroke survivor. Unadjusted means are presented here. |
| Caregiver Patient-Reported Outcomes Measurement Information System (PROMIS) Depression - Short Form 6a Score | Baseline, 2 months post-intervention | Depressive symptoms among caregivers was assessed with the 6-item PROMIS Depression - Short Form 6a instrument. Responses are given on a scale from 1 to 5 where 1 = never and 5 = always. Total scores range from 6 to 30 where higher scores indicate greater feelings of depression. Unadjusted means are presented here. |
| Neuro-QOL SF v1.0 - Upper Extremity Function (Fine Motor, ADL) Score | Baseline, 2 months post-intervention | Fine motor skills and activities of daily living (ADL) related to upper extremity function was assessed by Neuro-QOL SF v1.0 - Upper Extremity Function (Fine Motor, ADL). This is an 8-item, Likert-type scale assessing the respondent's ability to perform various manual activities of daily life. Responses are given on a 5-point scale where 1 = not at all and 5 = very much. The Neuro-QoL scores are standardized as T-scores with a mean of 50 and standard deviation of 10. Scores below 50 indicate below average upper extremity function. Unadjusted means are presented here. |
| Neuro-QoL Short Form v1.1 - Satisfaction With Social Roles and Activities Score Among Stroke Survivors | Baseline, 2 months post-intervention | Stroke survivor quality of life and social participation was assessed by the Neuro-QoL Short Form v1.1 - Satisfaction with Social Roles and Activities. This is an 8- item, Likert-type scale about satisfaction in the last 7 days. Neuro-QoL scores are presented as T-scores with a mean of 50 and standard deviation of 10. Scores below 50 indicate below average satisfaction with social roles and activities. Unadjusted means are presented here. |
| Family Care Climate Questionnaire - Stroke Survivor (FCCQ-SS) Score | Baseline, 2 months post-intervention | The Family Care Climate Questionnaire (FCCQ) for stroke survivors is 14-item questionnaire asking about experiences with family members in relation to rehabilitation activities. Each item is rated on a 7-point Likert scale ranging from 1 (not true at all) to 7 (very true). Item scores are averaged to provide an overall score between 1 and 7 where higher scores indicate the stroke survivor perceives receiving high autonomy support from the carepartner. Unadjusted means are presented here. |
| Family Caregiver Conflict Scale (FCCS) Score Among Carepartners | Baseline, 2 months post-intervention | Family conflict was assessed among carepartners with the FCCS. The FCCS is a unidimensional, Likert scale composed of 15 items. For each item, participants indicate their agreement with the item as 1 = not true at all, to 7 = very true. Item scores are summed and total scores range from 15 to 105, where higher scores represent higher levels of conflict within a family. Unadjusted means are presented here. |
| Confidence in Hand and Movement Scale (CAHM) Score | Baseline, 2 months post-intervention | Stroke survivor upper extremity self efficacy was assessed with the Confidence in Hand and Movement (CAHM) scale. The CAHM is 20-item instrument where items are scored on a scale of 0 (very uncertain) to 100 (very certain) and averaged to provide a total scale score ranging from 0 to 100. Higher scores indicate greater confidence with performing daily tasks with the impacted arm. Unadjusted means are presented here. |
| Family Assessment Device (FAD) Scale Score Among Carepartners | Baseline | The 12-item General Family Functioning scale from the McMaster Family Assessment Device measures general family functioning. Items are scored on a 4-point scale where 1 = healthy functioning and 4 = unhealthy functioning. A total score is obtained by summing the scores and calculating the average. Higher scores indicate ineffective family functioning. Unadjusted means are presented here. |
| Caregiver Strain Index (CSI) Score | Baseline, 2 months post-intervention | The CSI is a 13-question tool that measures strain related to care provision. Questions are responded to as either Yes or No and the total score is determined by summing the Yes responses. Total scores range from 0 to 13 and scores of 7 or more indicate high levels of stress. Unadjusted means are presented here. |
Countries
United States
Participant flow
Recruitment details
Participant enrollment began August 9, 2019 and all follow up was complete by December 21, 2021. Participants were enrolled from Emory Hospital in Atlanta, Georgia, USA.
Participants by arm
| Arm | Count |
|---|---|
| CARE-CITE Carepartner Carepartners receiving the CARE-CITE intervention | 17 |
| Control Carepartners Carepartners receiving customary care outpatient rehabilitation therapy but no CARE-CITE intervention | 6 |
| CARE-CITE Stroke Survivor Stroke survivors of carepartners receiving the CARE-CITE intervention | 17 |
| Control Stroke Survivors Stroke survivors receiving customary care outpatient rehabilitation therapy but no CARE-CITE intervention | 6 |
| Total | 46 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 | FG002 | FG003 |
|---|---|---|---|---|---|
| Overall Study | Withdrawal by Subject | 2 | 0 | 2 | 0 |
Baseline characteristics
| Characteristic | Control Carepartners | Total | Control Stroke Survivors | CARE-CITE Stroke Survivor | CARE-CITE Carepartner |
|---|---|---|---|---|---|
| Age, Continuous | 58.5 years STANDARD_DEVIATION 12.2 | 58.1 years STANDARD_DEVIATION 13.4 | 60.7 years STANDARD_DEVIATION 13.4 | 60.6 years STANDARD_DEVIATION 11.4 | 54.6 years STANDARD_DEVIATION 12.6 |
| Education 1-3 years of college | 3 Participants | 13 Participants | 4 Participants | 3 Participants | 3 Participants |
| Education 4 or more years of college | 3 Participants | 26 Participants | 2 Participants | 10 Participants | 11 Participants |
| Education High school or less | 0 Participants | 7 Participants | 0 Participants | 4 Participants | 3 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 1 Participants | 2 Participants | 1 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants | 5 Participants | 0 Participants | 3 Participants | 2 Participants |
| Race (NIH/OMB) Black or African American | 0 Participants | 17 Participants | 1 Participants | 8 Participants | 8 Participants |
| Race (NIH/OMB) More than one race | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants | 2 Participants | 0 Participants | 1 Participants | 1 Participants |
| Race (NIH/OMB) White | 5 Participants | 20 Participants | 4 Participants | 5 Participants | 6 Participants |
| Region of Enrollment United States | 6 Participants | 46 Participants | 6 Participants | 17 Participants | 17 Participants |
| Sex: Female, Male Female | 5 Participants | 29 Participants | 2 Participants | 9 Participants | 13 Participants |
| Sex: Female, Male Male | 1 Participants | 17 Participants | 4 Participants | 8 Participants | 4 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk | EG003 affected / at risk |
|---|---|---|---|---|
| deaths Total, all-cause mortality | 0 / 17 | 0 / 6 | 0 / 17 | 0 / 6 |
| other Total, other adverse events | 0 / 17 | 0 / 6 | 2 / 17 | 0 / 6 |
| serious Total, serious adverse events | 0 / 17 | 0 / 6 | 2 / 17 | 0 / 6 |
Outcome results
Center for Epidemiologic Studies - Depression (CES-D) Scale Score Among Carepartners
Depression among carepartners was assessed with the CES-D. The CES-D is 20-item, 4-point Likert-type scale where 0 = none/rare and 3 = most or all of the time. The scoring of positive items is reversed. The possible range of scores is 0 to 60, with the higher scores indicating the presence of more symptomatology. Unadjusted means are presented here.
Time frame: Baseline, 2 months post-intervention
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CARE-CITE Carepartner | Center for Epidemiologic Studies - Depression (CES-D) Scale Score Among Carepartners | Baseline | 9.9 score on a scale | Standard Deviation 9.7 |
| CARE-CITE Carepartner | Center for Epidemiologic Studies - Depression (CES-D) Scale Score Among Carepartners | 2 Months Post-intervention | 9.1 score on a scale | Standard Deviation 8.2 |
| Control Carepartners | Center for Epidemiologic Studies - Depression (CES-D) Scale Score Among Carepartners | Baseline | 11.2 score on a scale | Standard Deviation 8.5 |
| Control Carepartners | Center for Epidemiologic Studies - Depression (CES-D) Scale Score Among Carepartners | 2 Months Post-intervention | 9.3 score on a scale | Standard Deviation 4.8 |
Quality of Upper Extremity Function by Motor Activity Log (MAL) Score Among Stroke Survivors
The Motor Activity Log is 30-item questionnaire assessing use of the affected arm during normal daily activities. Responses are given on a Likert scale where 0 = the weaker arm was not used at all for that activity (never) to 5 = the ability to use the weaker arm for that activity was as good as before the stroke (normal). The total score is the average of all items and ranges from 0 to 5, where higher values indicate greater function of the arm that was impacted by the stroke. Unadjusted means are presented here.
Time frame: Baseline, 2 months post-intervention
Population: This analysis includes participants who completed both the Baseline and 2 Months Post-intervention assessment. One dyad in the CARE-CITE study arm withdrew from the study after completing some of the questionnaires of the 2 Months-Post intervention evaluation but did not complete the remote assessment in which the MAL was administered.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CARE-CITE Carepartner | Quality of Upper Extremity Function by Motor Activity Log (MAL) Score Among Stroke Survivors | Baseline | 2.4 score on a scale | Standard Deviation 1.3 |
| CARE-CITE Carepartner | Quality of Upper Extremity Function by Motor Activity Log (MAL) Score Among Stroke Survivors | 2 Months Post-intervention | 3.4 score on a scale | Standard Deviation 1 |
| Control Carepartners | Quality of Upper Extremity Function by Motor Activity Log (MAL) Score Among Stroke Survivors | Baseline | 2.2 score on a scale | Standard Deviation 1.1 |
| Control Carepartners | Quality of Upper Extremity Function by Motor Activity Log (MAL) Score Among Stroke Survivors | 2 Months Post-intervention | 3.3 score on a scale | Standard Deviation 1.2 |
Short Form Health Survey (SF-36) Scale Score Among Carepartners
Carepartner quality of life was assessed with the SF-36. The SF-36 is a 36-item Likert-type scale, mental health domain. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. Lower scores indicate greater disability, while higher scores indicate less disability (i.e. a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability). Unadjusted means are presented here.
Time frame: Baseline, 2 months post-intervention
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CARE-CITE Carepartner | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Physical Functioning - Baseline | 73.9 score on a scale | Standard Deviation 21.6 |
| CARE-CITE Carepartner | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Physical Functioning - 2 Months Post-intervention | 82.3 score on a scale | Standard Deviation 13.1 |
| CARE-CITE Carepartner | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Role Limitation, Physical - Baseline | 70.6 score on a scale | Standard Deviation 42.6 |
| CARE-CITE Carepartner | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Role Limitation, Physical - 2 Months Post-intervention | 76.7 score on a scale | Standard Deviation 38.3 |
| CARE-CITE Carepartner | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Role Limitation, Emotional - Baseline | 70.6 score on a scale | Standard Deviation 30.4 |
| CARE-CITE Carepartner | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Role Limitation, Emotional - 2 Months Post-intervention | 82.2 score on a scale | Standard Deviation 18.3 |
| CARE-CITE Carepartner | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Energy/Vitality - Baseline | 58.2 score on a scale | Standard Deviation 21.1 |
| CARE-CITE Carepartner | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Energy/Vitality - 2 Months Post-intervention | 64.0 score on a scale | Standard Deviation 16.4 |
| CARE-CITE Carepartner | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Emotional Well Being - Baseline | 74.6 score on a scale | Standard Deviation 18.9 |
| CARE-CITE Carepartner | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Emotional Well Being - 2 Months Post-intervention | 76.3 score on a scale | Standard Deviation 16 |
| CARE-CITE Carepartner | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Social Functioning - Baseline | 76.5 score on a scale | Standard Deviation 22.5 |
| CARE-CITE Carepartner | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Social Functioning - 2 Months Post-intervention | 83.3 score on a scale | Standard Deviation 23.5 |
| CARE-CITE Carepartner | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Pain - Baseline | 81.0 score on a scale | Standard Deviation 16.8 |
| CARE-CITE Carepartner | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Pain - 2 Months Post-intervention | 77.2 score on a scale | Standard Deviation 22.6 |
| CARE-CITE Carepartner | Short Form Health Survey (SF-36) Scale Score Among Carepartners | General Health - Baseline | 67.4 score on a scale | Standard Deviation 10.5 |
| CARE-CITE Carepartner | Short Form Health Survey (SF-36) Scale Score Among Carepartners | General Health - 2 Months Post-intervention | 71.0 score on a scale | Standard Deviation 9.7 |
| Control Carepartners | Short Form Health Survey (SF-36) Scale Score Among Carepartners | General Health - 2 Months Post-intervention | 76.7 score on a scale | Standard Deviation 5.2 |
| Control Carepartners | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Physical Functioning - Baseline | 92.5 score on a scale | Standard Deviation 8.2 |
| Control Carepartners | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Emotional Well Being - Baseline | 74.0 score on a scale | Standard Deviation 12.3 |
| Control Carepartners | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Physical Functioning - 2 Months Post-intervention | 85.8 score on a scale | Standard Deviation 15.6 |
| Control Carepartners | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Pain - Baseline | 78.8 score on a scale | Standard Deviation 13.9 |
| Control Carepartners | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Role Limitation, Physical - Baseline | 83.3 score on a scale | Standard Deviation 20.4 |
| Control Carepartners | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Emotional Well Being - 2 Months Post-intervention | 81.3 score on a scale | Standard Deviation 12.8 |
| Control Carepartners | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Role Limitation, Physical - 2 Months Post-intervention | 70.8 score on a scale | Standard Deviation 45.9 |
| Control Carepartners | Short Form Health Survey (SF-36) Scale Score Among Carepartners | General Health - Baseline | 72.5 score on a scale | Standard Deviation 7.6 |
| Control Carepartners | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Role Limitation, Emotional - Baseline | 91.7 score on a scale | Standard Deviation 13.9 |
| Control Carepartners | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Social Functioning - Baseline | 83.3 score on a scale | Standard Deviation 30.3 |
| Control Carepartners | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Role Limitation, Emotional - 2 Months Post-intervention | 83.3 score on a scale | Standard Deviation 14.9 |
| Control Carepartners | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Pain - 2 Months Post-intervention | 73.8 score on a scale | Standard Deviation 31.7 |
| Control Carepartners | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Energy/Vitality - Baseline | 47.5 score on a scale | Standard Deviation 27.2 |
| Control Carepartners | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Social Functioning - 2 Months Post-intervention | 83.3 score on a scale | Standard Deviation 21.9 |
| Control Carepartners | Short Form Health Survey (SF-36) Scale Score Among Carepartners | Energy/Vitality - 2 Months Post-intervention | 55.0 score on a scale | Standard Deviation 28.1 |
Stroke Impact Scale (SIS) Score Among Stroke Survivors
Quality of life among stroke survivors was assessed with the Stroke Impact Scale (SIS). The SIS is a stroke specific, self report questionnaire (59 items across 8 domains) that measures how a stroke has impacted a participant's health and life, including strength, memory and thinking, emotions and mood, communication, activities of daily living, mobility, function of affected upper extremity, and social participation. Each item is rated in a 5-point Likert scale in terms of the difficulty the participant has experienced in completing each item. A score for each domain is obtained, ranging from 0 to 100 where higher scores indicate greater ability to perform tasks. Unadjusted means are presented here.
Time frame: Baseline, 2 months post-intervention
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CARE-CITE Carepartner | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Activities of Daily Living Domain Score - Baseline | 50.7 score on a scale | Standard Deviation 15.3 |
| CARE-CITE Carepartner | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Communication Domain Score - Baseline | 84.9 score on a scale | Standard Deviation 27.7 |
| CARE-CITE Carepartner | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Activities of Daily Living Domain Score - 2 Months Post-Intervention | 59.5 score on a scale | Standard Deviation 15.7 |
| CARE-CITE Carepartner | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Emotions and Mood Domain Score - Baseline | 60.0 score on a scale | Standard Deviation 10.7 |
| CARE-CITE Carepartner | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Mobility Domain Score - Baseline | 45.9 score on a scale | Standard Deviation 23 |
| CARE-CITE Carepartner | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Strength Domain Score - 2 Months Post-Intervention | 64.2 score on a scale | Standard Deviation 19.5 |
| CARE-CITE Carepartner | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Mobility Domain Score - 2 Months Post-Intervention | 55.3 score on a scale | Standard Deviation 15.3 |
| CARE-CITE Carepartner | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Emotions and Mood Domain Score - 2 Months Post-Intervention | 60.3 score on a scale | Standard Deviation 14 |
| CARE-CITE Carepartner | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Function of Affected Upper Extremity Domain Score - Baseline | 37.4 score on a scale | Standard Deviation 22 |
| CARE-CITE Carepartner | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Strength Domain Score - Baseline | 50.4 score on a scale | Standard Deviation 21.7 |
| CARE-CITE Carepartner | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Function of Affected Upper Extremity Domain Score - 2 Months Post-Intervention | 46.7 score on a scale | Standard Deviation 22 |
| CARE-CITE Carepartner | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Memory and Thinking Domain Score - Baseline | 76.3 score on a scale | Standard Deviation 28.5 |
| CARE-CITE Carepartner | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Social Participation Domain Score - Baseline | 34.3 score on a scale | Standard Deviation 21.1 |
| CARE-CITE Carepartner | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Communication Domain Score - 2 Months Post-Intervention | 88.8 score on a scale | Standard Deviation 18.4 |
| CARE-CITE Carepartner | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Social Participation Domain Score - 2 Months Post-Intervention | 50.0 score on a scale | Standard Deviation 18.6 |
| CARE-CITE Carepartner | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Memory and Thinking Domain Score - 2 Months Post-Intervention | 91.7 score on a scale | Standard Deviation 12 |
| Control Carepartners | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Social Participation Domain Score - 2 Months Post-Intervention | 32.1 score on a scale | Standard Deviation 9.7 |
| Control Carepartners | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Strength Domain Score - Baseline | 56.3 score on a scale | Standard Deviation 10.5 |
| Control Carepartners | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Strength Domain Score - 2 Months Post-Intervention | 58.3 score on a scale | Standard Deviation 10.9 |
| Control Carepartners | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Memory and Thinking Domain Score - 2 Months Post-Intervention | 82.7 score on a scale | Standard Deviation 22.2 |
| Control Carepartners | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Emotions and Mood Domain Score - Baseline | 61.5 score on a scale | Standard Deviation 10.4 |
| Control Carepartners | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Emotions and Mood Domain Score - 2 Months Post-Intervention | 55.2 score on a scale | Standard Deviation 15.4 |
| Control Carepartners | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Communication Domain Score - Baseline | 76.8 score on a scale | Standard Deviation 23.2 |
| Control Carepartners | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Communication Domain Score - 2 Months Post-Intervention | 78.0 score on a scale | Standard Deviation 22.5 |
| Control Carepartners | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Activities of Daily Living Domain Score - Baseline | 46.7 score on a scale | Standard Deviation 14.4 |
| Control Carepartners | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Activities of Daily Living Domain Score - 2 Months Post-Intervention | 63.7 score on a scale | Standard Deviation 10.6 |
| Control Carepartners | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Mobility Domain Score - Baseline | 57.0 score on a scale | Standard Deviation 12.3 |
| Control Carepartners | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Mobility Domain Score - 2 Months Post-Intervention | 62.2 score on a scale | Standard Deviation 16.8 |
| Control Carepartners | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Function of Affected Upper Extremity Domain Score - Baseline | 25.3 score on a scale | Standard Deviation 15.7 |
| Control Carepartners | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Function of Affected Upper Extremity Domain Score - 2 Months Post-Intervention | 51.3 score on a scale | Standard Deviation 27.1 |
| Control Carepartners | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Social Participation Domain Score - Baseline | 33.3 score on a scale | Standard Deviation 26.7 |
| Control Carepartners | Stroke Impact Scale (SIS) Score Among Stroke Survivors | Memory and Thinking Domain Score - Baseline | 73.8 score on a scale | Standard Deviation 16.1 |
Wolf Motor Function Test (WMFT) Test Time Among Stroke Survivors
The Wolf Motor Function Test (WMFT) assesses upper extremity motor ability with 17 functional tasks (15 timed and 2 strength tasks). The time, in seconds, required to complete each of 15 timed scores is calculated, with lower times (faster speeds) indicating higher functioning levels. Unadjusted means are presented here.
Time frame: Baseline, 2 months post-intervention
Population: The WMFT is an in-person assessment and administration of the WMFT was stopped after the study converted to fully remote delivery due to Coronavirus Disease 2019 (COVID-19) pandemic health restrictions which limited in-person visits. This analysis includes participants who completed the WMFT assessment prior to the study being conducted remotely.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CARE-CITE Carepartner | Wolf Motor Function Test (WMFT) Test Time Among Stroke Survivors | Baseline | 4.2 seconds | Standard Deviation 3.9 |
| CARE-CITE Carepartner | Wolf Motor Function Test (WMFT) Test Time Among Stroke Survivors | 2 Months Post-intervention | 2.8 seconds | Standard Deviation 0.3 |
| Control Carepartners | Wolf Motor Function Test (WMFT) Test Time Among Stroke Survivors | Baseline | 27.9 seconds | Standard Deviation 34.4 |
| Control Carepartners | Wolf Motor Function Test (WMFT) Test Time Among Stroke Survivors | 2 Months Post-intervention | 2.7 seconds | Standard Deviation 0.8 |
Wolf Motor Function Test (WMFT) Upper Extremity Function Ability Score (FAS)
The Wolf Motor Function Test (WMFT) assesses upper extremity motor ability with 17 timed and functional tasks (15 timed and 2 strength tasks). Functional ability for each task is scored from 0 to 5, where 0 = does not attempt with upper extremity being tested, and 5 = movement appears to be normal. Total scores range from 0 to 85 and lower scores indicate lower functional ability. Unadjusted means are presented here.
Time frame: Baseline, 2 months post-intervention
Population: The WMFT is an in-person assessment and administration of the WMFT was stopped after the study converted to fully remote delivery due to Coronavirus Disease 2019 (COVID-19) pandemic health restrictions which limited in-person visits. This analysis includes participants who completed the WMFT assessment prior to the study being conducted remotely.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CARE-CITE Carepartner | Wolf Motor Function Test (WMFT) Upper Extremity Function Ability Score (FAS) | Baseline | 59.0 score on a scale | Standard Deviation 3.9 |
| CARE-CITE Carepartner | Wolf Motor Function Test (WMFT) Upper Extremity Function Ability Score (FAS) | 2 Months Post-intervention | 59.5 score on a scale | Standard Deviation 7.8 |
| Control Carepartners | Wolf Motor Function Test (WMFT) Upper Extremity Function Ability Score (FAS) | Baseline | 43.0 score on a scale | Standard Deviation 5.7 |
| Control Carepartners | Wolf Motor Function Test (WMFT) Upper Extremity Function Ability Score (FAS) | 2 Months Post-intervention | 55.5 score on a scale | Standard Deviation 0.7 |
Bakas Caregiving Outcomes Scale (BCOS) Score
The BCOS is a unidimensional scale based on 15 items and addresses changes in caregiving social functioning, subjective well-being and physical health. Carepartners respond to statements on a 7-point Likert scale where 1 = changed for the worst, and 7 = changed for the best. Total scores range from 15 - 105 with higher scores representing more positive caregiving outcomes since the stroke. Unadjusted means are presented here.
Time frame: Baseline, 2 months post-intervention
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CARE-CITE Carepartner | Bakas Caregiving Outcomes Scale (BCOS) Score | Baseline | 57.8 score on a scale | Standard Deviation 13.6 |
| CARE-CITE Carepartner | Bakas Caregiving Outcomes Scale (BCOS) Score | 2 Months Post-intervention | 59.9 score on a scale | Standard Deviation 8.6 |
| Control Carepartners | Bakas Caregiving Outcomes Scale (BCOS) Score | Baseline | 53.5 score on a scale | Standard Deviation 5.8 |
| Control Carepartners | Bakas Caregiving Outcomes Scale (BCOS) Score | 2 Months Post-intervention | 55.7 score on a scale | Standard Deviation 4.3 |
Caregiver Patient-Reported Outcomes Measurement Information System (PROMIS) Depression - Short Form 6a Score
Depressive symptoms among caregivers was assessed with the 6-item PROMIS Depression - Short Form 6a instrument. Responses are given on a scale from 1 to 5 where 1 = never and 5 = always. Total scores range from 6 to 30 where higher scores indicate greater feelings of depression. Unadjusted means are presented here.
Time frame: Baseline, 2 months post-intervention
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CARE-CITE Carepartner | Caregiver Patient-Reported Outcomes Measurement Information System (PROMIS) Depression - Short Form 6a Score | Baseline | 9.1 score on a scale | Standard Deviation 3.9 |
| CARE-CITE Carepartner | Caregiver Patient-Reported Outcomes Measurement Information System (PROMIS) Depression - Short Form 6a Score | 2 Months Post-intervention | 8.6 score on a scale | Standard Deviation 3.8 |
| Control Carepartners | Caregiver Patient-Reported Outcomes Measurement Information System (PROMIS) Depression - Short Form 6a Score | Baseline | 9.5 score on a scale | Standard Deviation 2.9 |
| Control Carepartners | Caregiver Patient-Reported Outcomes Measurement Information System (PROMIS) Depression - Short Form 6a Score | 2 Months Post-intervention | 9.0 score on a scale | Standard Deviation 2.3 |
Caregiver Strain Index (CSI) Score
The CSI is a 13-question tool that measures strain related to care provision. Questions are responded to as either Yes or No and the total score is determined by summing the Yes responses. Total scores range from 0 to 13 and scores of 7 or more indicate high levels of stress. Unadjusted means are presented here.
Time frame: Baseline, 2 months post-intervention
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CARE-CITE Carepartner | Caregiver Strain Index (CSI) Score | Baseline | 4.8 score on a scale | Standard Deviation 3.3 |
| CARE-CITE Carepartner | Caregiver Strain Index (CSI) Score | 2 Months Post-intervention | 4.5 score on a scale | Standard Deviation 3.9 |
| Control Carepartners | Caregiver Strain Index (CSI) Score | Baseline | 3.7 score on a scale | Standard Deviation 3.3 |
| Control Carepartners | Caregiver Strain Index (CSI) Score | 2 Months Post-intervention | 4.0 score on a scale | Standard Deviation 3.4 |
Confidence in Hand and Movement Scale (CAHM) Score
Stroke survivor upper extremity self efficacy was assessed with the Confidence in Hand and Movement (CAHM) scale. The CAHM is 20-item instrument where items are scored on a scale of 0 (very uncertain) to 100 (very certain) and averaged to provide a total scale score ranging from 0 to 100. Higher scores indicate greater confidence with performing daily tasks with the impacted arm. Unadjusted means are presented here.
Time frame: Baseline, 2 months post-intervention
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CARE-CITE Carepartner | Confidence in Hand and Movement Scale (CAHM) Score | Baseline | 48.8 score on a scale | Standard Deviation 29.2 |
| CARE-CITE Carepartner | Confidence in Hand and Movement Scale (CAHM) Score | 2 Months Post-intervention | 67.1 score on a scale | Standard Deviation 24 |
| Control Carepartners | Confidence in Hand and Movement Scale (CAHM) Score | Baseline | 50.5 score on a scale | Standard Deviation 28.2 |
| Control Carepartners | Confidence in Hand and Movement Scale (CAHM) Score | 2 Months Post-intervention | 59.5 score on a scale | Standard Deviation 29.9 |
Family Assessment Device (FAD) Scale Score Among Carepartners
The 12-item General Family Functioning scale from the McMaster Family Assessment Device measures general family functioning. Items are scored on a 4-point scale where 1 = healthy functioning and 4 = unhealthy functioning. A total score is obtained by summing the scores and calculating the average. Higher scores indicate ineffective family functioning. Unadjusted means are presented here.
Time frame: Baseline
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CARE-CITE Carepartner | Family Assessment Device (FAD) Scale Score Among Carepartners | 1.77 score on a scale | Standard Deviation 0.37 |
| Control Carepartners | Family Assessment Device (FAD) Scale Score Among Carepartners | 1.78 score on a scale | Standard Deviation 0.33 |
Family Care Climate Questionnaire - Carepartners (FCCQ-CP) Score
The Family Care Climate Questionnaire (FCCQ) for carepartners is 14-item questionnaire asking about the carepartners' experiences with the strokes survivor in relation to their rehabilitation activities. Each item is rated on a 7-point Likert scale ranging from 1 (not true at all) to 7 (very true). Item scores are averaged to provide an overall score between 1 and 7 where higher scores indicate the carepartner thinks they are providing high autonomy support to the stroke survivor. Unadjusted means are presented here.
Time frame: Baseline, 2 months post-intervention
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CARE-CITE Carepartner | Family Care Climate Questionnaire - Carepartners (FCCQ-CP) Score | Baseline | 6.3 score on a scale | Standard Deviation 0.6 |
| CARE-CITE Carepartner | Family Care Climate Questionnaire - Carepartners (FCCQ-CP) Score | 2 Months Post-intervention | 6.4 score on a scale | Standard Deviation 0.3 |
| Control Carepartners | Family Care Climate Questionnaire - Carepartners (FCCQ-CP) Score | Baseline | 6.4 score on a scale | Standard Deviation 0.4 |
| Control Carepartners | Family Care Climate Questionnaire - Carepartners (FCCQ-CP) Score | 2 Months Post-intervention | 6.6 score on a scale | Standard Deviation 0.6 |
Family Care Climate Questionnaire - Stroke Survivor (FCCQ-SS) Score
The Family Care Climate Questionnaire (FCCQ) for stroke survivors is 14-item questionnaire asking about experiences with family members in relation to rehabilitation activities. Each item is rated on a 7-point Likert scale ranging from 1 (not true at all) to 7 (very true). Item scores are averaged to provide an overall score between 1 and 7 where higher scores indicate the stroke survivor perceives receiving high autonomy support from the carepartner. Unadjusted means are presented here.
Time frame: Baseline, 2 months post-intervention
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CARE-CITE Carepartner | Family Care Climate Questionnaire - Stroke Survivor (FCCQ-SS) Score | Baseline | 6.6 score on a scale | Standard Deviation 0.4 |
| CARE-CITE Carepartner | Family Care Climate Questionnaire - Stroke Survivor (FCCQ-SS) Score | 2 Months Post-intervention | 6.7 score on a scale | Standard Deviation 0.4 |
| Control Carepartners | Family Care Climate Questionnaire - Stroke Survivor (FCCQ-SS) Score | Baseline | 6.5 score on a scale | Standard Deviation 0.4 |
| Control Carepartners | Family Care Climate Questionnaire - Stroke Survivor (FCCQ-SS) Score | 2 Months Post-intervention | 6.3 score on a scale | Standard Deviation 1 |
Family Caregiver Conflict Scale (FCCS) Score Among Carepartners
Family conflict was assessed among carepartners with the FCCS. The FCCS is a unidimensional, Likert scale composed of 15 items. For each item, participants indicate their agreement with the item as 1 = not true at all, to 7 = very true. Item scores are summed and total scores range from 15 to 105, where higher scores represent higher levels of conflict within a family. Unadjusted means are presented here.
Time frame: Baseline, 2 months post-intervention
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CARE-CITE Carepartner | Family Caregiver Conflict Scale (FCCS) Score Among Carepartners | Baseline | 21.6 score on a scale | Standard Deviation 10.2 |
| CARE-CITE Carepartner | Family Caregiver Conflict Scale (FCCS) Score Among Carepartners | 2 Months Post-intervention | 20.9 score on a scale | Standard Deviation 8.5 |
| Control Carepartners | Family Caregiver Conflict Scale (FCCS) Score Among Carepartners | Baseline | 19.3 score on a scale | Standard Deviation 9.7 |
| Control Carepartners | Family Caregiver Conflict Scale (FCCS) Score Among Carepartners | 2 Months Post-intervention | 20.2 score on a scale | Standard Deviation 6 |
Fugl-Meyer Assessment (FMA) Upper Extremity Motor Score
Upper extremity impairment was assessed by the Fugl-Meyer Assessment (FMA). The FMA evaluates and measures recovery in post-stroke hemiplegic patients with 5 domains: motor score (which is further separated for upper and lower extremity), sensation, balance, joint range of motion, and joint pain. Items are scored on a 3-point ordinal scale where 0 = cannot perform and 3 = performs fully. The total score for the upper extremity motor domain ranges from 0 to 66 and a higher score indicates greater arm function. Unadjusted means are presented here.
Time frame: Baseline, 2 months post-intervention
Population: This analysis includes participants who completed both the Baseline and 2 Months Post-intervention assessment. One dyad in the CARE-CITE study arm withdrew from the study after completing some of the questionnaires of the 2 Months Post-intervention evaluation but did not complete the remote assessment in which the FMA was administered.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CARE-CITE Carepartner | Fugl-Meyer Assessment (FMA) Upper Extremity Motor Score | Baseline | 46.8 score on a scale | Standard Deviation 12.2 |
| CARE-CITE Carepartner | Fugl-Meyer Assessment (FMA) Upper Extremity Motor Score | 2 Months Post-intervention | 50.7 score on a scale | Standard Deviation 8.4 |
| Control Carepartners | Fugl-Meyer Assessment (FMA) Upper Extremity Motor Score | Baseline | 49.0 score on a scale | Standard Deviation 10 |
| Control Carepartners | Fugl-Meyer Assessment (FMA) Upper Extremity Motor Score | 2 Months Post-intervention | 55.3 score on a scale | Standard Deviation 6 |
Neuro-QOL SF v1.0 - Upper Extremity Function (Fine Motor, ADL) Score
Fine motor skills and activities of daily living (ADL) related to upper extremity function was assessed by Neuro-QOL SF v1.0 - Upper Extremity Function (Fine Motor, ADL). This is an 8-item, Likert-type scale assessing the respondent's ability to perform various manual activities of daily life. Responses are given on a 5-point scale where 1 = not at all and 5 = very much. The Neuro-QoL scores are standardized as T-scores with a mean of 50 and standard deviation of 10. Scores below 50 indicate below average upper extremity function. Unadjusted means are presented here.
Time frame: Baseline, 2 months post-intervention
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CARE-CITE Carepartner | Neuro-QOL SF v1.0 - Upper Extremity Function (Fine Motor, ADL) Score | Baseline | 29.6 score on a scale | Standard Deviation 6.7 |
| CARE-CITE Carepartner | Neuro-QOL SF v1.0 - Upper Extremity Function (Fine Motor, ADL) Score | 2 Months Post-intervention | 35.4 score on a scale | Standard Deviation 7.7 |
| Control Carepartners | Neuro-QOL SF v1.0 - Upper Extremity Function (Fine Motor, ADL) Score | Baseline | 32.8 score on a scale | Standard Deviation 13.6 |
| Control Carepartners | Neuro-QOL SF v1.0 - Upper Extremity Function (Fine Motor, ADL) Score | 2 Months Post-intervention | 33.6 score on a scale | Standard Deviation 11.7 |
Neuro-QoL Short Form v1.1 - Satisfaction With Social Roles and Activities Score Among Stroke Survivors
Stroke survivor quality of life and social participation was assessed by the Neuro-QoL Short Form v1.1 - Satisfaction with Social Roles and Activities. This is an 8- item, Likert-type scale about satisfaction in the last 7 days. Neuro-QoL scores are presented as T-scores with a mean of 50 and standard deviation of 10. Scores below 50 indicate below average satisfaction with social roles and activities. Unadjusted means are presented here.
Time frame: Baseline, 2 months post-intervention
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CARE-CITE Carepartner | Neuro-QoL Short Form v1.1 - Satisfaction With Social Roles and Activities Score Among Stroke Survivors | Baseline | 44.2 score on a scale | Standard Deviation 3.4 |
| CARE-CITE Carepartner | Neuro-QoL Short Form v1.1 - Satisfaction With Social Roles and Activities Score Among Stroke Survivors | 2 Months Post-intervention | 45.6 score on a scale | Standard Deviation 4.8 |
| Control Carepartners | Neuro-QoL Short Form v1.1 - Satisfaction With Social Roles and Activities Score Among Stroke Survivors | 2 Months Post-intervention | 45.0 score on a scale | Standard Deviation 7.7 |
| Control Carepartners | Neuro-QoL Short Form v1.1 - Satisfaction With Social Roles and Activities Score Among Stroke Survivors | Baseline | 43.2 score on a scale | Standard Deviation 4.8 |